13D Filing: OrbiMed Advisors and Synlogic Inc. (SYBX)

Page 3 of 11

Page 3 of 11 – SEC Filing

CUSIP No. 87166L100
Page 3 of 13 Pages
1
NAME OF REPORTING PERSON

OrbiMed Capital GP VI LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
(b)
3
SEC USE ONLY
4
SOURCE OF FUNDS (See Instructions)

AF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware
NUMBER OF SHARES
BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH
7
SOLE VOTING POWER

0
8
SHARED VOTING POWER
1,314,996
9
SOLE DISPOSITIVE POWER

0
10
SHARED DISPOSITIVE POWER

 

1,314,996
11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,314,996
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  (See Instructions)
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

8.08%*
14
TYPE OF REPORTING PERSON (See Instructions)

OO

* This percentage is calculated based upon 16,282,496 shares of common stock outstanding of Synlogic, Inc. (the “Issuer”), as set forth in the Issuer’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 28, 2017.

Follow Synlogic Inc. (NASDAQ:SYBX)

Page 3 of 11